Steven Lichtman's Stock Ratings

Oppenheimer Analyst

Steven Lichtman is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/23/2024

Overall Average Return

19.4%

Smart Score

67.4%

Overall Average Return Percentile

77th

Number of Ratings

79
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst
Oppenheimer predicts growth for Penumbra Inc in MT market. Analyst initiates coverage with Outperform rating and $275 target price.
Key Takeaways From DexCom Analyst Ratings
Analyst Expectations For Medtronic's Future
What 21 Analyst Ratings Have To Say About Zimmer Biomet Holdings
Analyst Scoreboard: 7 Ratings For RxSight
Medtronic Stock: A Deep Dive Into Analyst Perspectives (15 Ratings)
Analyst Expectations For DexCom's Future
These Analysts Revise Their Forecasts On DexCom Following Q3 Results
McDonald's To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Analyst Expectations For Zimmer Biomet Holdings's Future
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved